Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Ionomycin free acid (AC172)
Cat.#: ASSD-172
Specifications
Description Ionomycin free acid is a potent calcium ionophore which shows selectivity for Ca2+ over Mg2+ and K+. Size 1mg, 5mg Chemical Name (4R,6S,8S,10Z,12R,14R,16E,18R,19R,20S,21S)-11,19,21-Trihydroxy-4,6,8,12,14,18,20-heptamethyl-22-[(2S,2'R,5S,5'S)-octahydro-5'-[(1R)-1-hydroxyethyl]-2,5'-dimethyl[2,2'-bifuran]-5-yl]-9-oxo-10,16-docosadienoic acid Molecule Weight 709.01 Molecular formula C41H72O9 CAS Number 56092-81-0 PubChem identifier 6912226 MDL Number MFCD06798385 Purity >98% Solubility Soluble in ethanol (10 mM) and DMSO (10 mM) Form White to off-white Storage Store at -20° C Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ASSD-194 7-(Diethylamino)coumarin-3-carboxylic acid (AC194) 100 mg inquiry ASSD-138 A3AR covalent antagonist (AC138) 50 μg inquiry ASSD-116 Annexin V-FITC Apoptosis Staining / Detection Kit (AC116) 1 kit, 100 tests inquiry ASSD-129 Fluorescent 5-HT1A antagonist [NAN-190] (AC129) 50 μg inquiry ASSD-106 Hoechst 33342 Staining Solution (10mg/ml) (AC106) 5 mL, 10 mL inquiry ASSD-123 Fluorescent β2 antagonist [(S)-propranolol-red] (AC123) 500 μg inquiry ASSD-115 7-Amino-4-methylcoumarin (AC115) 100 mg, 500 mg, 1 g inquiry ASSD-197 Sulforhodamine 101 acid chloride (AC197) 10 mg, 25 mg inquiry ASSD-216 K 114 (AC216) 10 mg, 50 mg inquiry ASSD-226 Antifade Fluorescence Mounting Medium (hard set) (AC226) 10 mL inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket